Related references
Note: Only part of the references are listed.Association of TLR4 gene polymorphisms with sporadic Parkinson's disease in a Han Chinese population
Jing Zhao et al.
NEUROLOGICAL SCIENCES (2015)
THE RELATION BETWEEN α-SYNUCLEIN AND MICROGLIA IN PARKINSON'S DISEASE: RECENT DEVELOPMENTS
V. Sanchez-Guajardo et al.
NEUROSCIENCE (2015)
MHCII Is Required for α-Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneratione
Ashley S. Harms et al.
JOURNAL OF NEUROSCIENCE (2013)
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
Carmen Noelker et al.
SCIENTIFIC REPORTS (2013)
S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-α pathway
Kinnari Sathe et al.
BRAIN (2012)
alpha-Synuclein alters toll-like receptor expression
Dawn Beraud et al.
FRONTIERS IN NEUROSCIENCE (2011)
The Multifaceted Profile of Activated Microglia
Marina A. Lynch
MOLECULAR NEUROBIOLOGY (2009)
Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease
Dirk W. Luchtman et al.
PHYSIOLOGY & BEHAVIOR (2009)
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
Maria Clara Pott Godoy et al.
BRAIN (2008)
Lipopolysaccharide-activated IL-10-secreting dendritic cells suppress experimental autoimmune uveoretinitis by MHCII-dependent activation of CD62L-expressing regulatory T cells
Annie W. T. Lau et al.
JOURNAL OF IMMUNOLOGY (2008)
Nitrated alpha-synuclein and microglial neuroregulatory activities
Ashley D. Reynolds et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Inflammatory changes parallel the early stages of Alzheimer disease
A. Parachikova et al.
NEUROBIOLOGY OF AGING (2007)
Involvement of interferon-γ in microglial-mediated loss of dopaminergic neurons
Matthew P. Mount et al.
JOURNAL OF NEUROSCIENCE (2007)
The effect of activated microglia on astrogliosis parameters in astrocyte cultures
Claudia Roehl et al.
BRAIN RESEARCH (2007)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Genetic ablation of tumor necrosis factor-alpha (TNF-α) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum
B Ferger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a dopaminergic neurotoxin
G Hébert et al.
NEUROSCIENCE LETTERS (2003)
Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice
H Cardenas et al.
BRAIN RESEARCH (2003)
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
P Teismann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis
U Eriksson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Neuroinflammatory processes in Parkinson's disease
S Hunot et al.
ANNALS OF NEUROLOGY (2003)
Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice
LM Bolin et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Glial cell influence on the human blood-brain barrier
A Prat et al.
GLIA (2001)
Share Paper
